MeiraGTx Holdings - Stock Price History | MGTX

Historical daily share price chart and data for MeiraGTx Holdings since 2021 adjusted for splits. The latest closing stock price for MeiraGTx Holdings as of September 27, 2021 is 13.59.
  • The all-time high MeiraGTx Holdings stock closing price was 30.01 on July 09, 2019.
  • The MeiraGTx Holdings 52-week high stock price is 18.45, which is 35.8% above the current share price.
  • The MeiraGTx Holdings 52-week low stock price is 11.60, which is 14.6% below the current share price.
  • The average MeiraGTx Holdings stock price for the last 52 weeks is 14.43.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
MeiraGTx Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 14.5150 19.7200 21.2400 9.3100 15.1400 -24.38%
2019 18.8299 9.8300 30.0100 9.2000 20.0200 107.68%
2018 11.9023 15.0000 15.0000 8.1000 9.6400 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.602B $0.016B
MeiraGTx Holdings plc focuses on operating as a holding company for MeiraGTx Limited which operates as a clinical stage gene therapy company. It develops novel gene therapy treatments for inherited and acquired disorders. The company's product pipeline consists of AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, AAV-AQP1 and AAV-UPF1 which are in clinical stage. MeiraGTx Holdings plc is based in New York.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29